Skip to main content
| News

Basel is artificial intelligence hub

03.09.2019

The canton of Basel-Stadt is one of the three largest Swiss technology clusters for advanced digitalization technologies, as the new Digitalization Atlas has revealed. It is especially strong in artificial intelligence, with Roche, in particular, filing many patents in this area.

Digitalization Atlas of Switzerland for the technology Artificial Intelligence (Image: EconSight)

The economic research and consulting company EconSight has published its latest Digitalization Atlas. In this, it examines the patent activities of companies in advanced digitalization technologies across the various regions of Switzerland, with the aim of highlighting where local technology clusters can be found.

According to the results, the canton of Basel-Stadt is one of the three largest clusters for advanced digitalization technologies in Switzerland. With these technologies, EconSight means artificial intelligence, encryption, big data, cloud computing and virtual reality. In total, companies and research facilities in the canton of Basel-Stadt have filed 202 patents in these areas.

According to the Digitalization Atlas, the technological focus of Basel-Stadt is artificial intelligence, with 75 percent of advanced digitalization patents within this field. This trend is above all driven by the Basel-based pharma giant Roche. In Switzerland, Roche holds the highest number of patents in artificial intelligence (115 patents). Roche is followed by Zurich technology company ABB (108 patents) and, by quite some margin, Google’s parent company Alphabet (40 patents).

Roche remains the clear leader even when all five technology categories are taken into account. With 149 patents, the Group ranks third behind the Western Swiss company Kudelski (213 patents) and ABB (196 patents).

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Noema Pharma raises 103 million Swiss francs from investors
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Read More
Basel still the most attractive small city for business in Europe
Basel Area Business & Innovation, Innovation, Invest

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Read More
Ariceum Therapeutics establishes subsidiary in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

Read More
RocketVax raises fresh capital
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

RocketVax raises fresh capital

The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...

Read More
Clinerion is now part of Citeline
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion is now part of Citeline

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...

Read More
KUORI developing biodegradable plastics
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Cell and gene therapies gain momentum in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
AMR Action Fund invests in new antibiotics developed by BioVersys
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.